Your browser doesn't support javascript.
loading
Plasma transfusion in critically Ill patients with abnormal coagulation tests before invasive procedures: A propensity-adjusted cohort study.
Ren, Qi; Zhao, Jie; He, Xuehua; Su, Li; Chai, Juchuan; Bai, Lingling; Ao, Zhengcai; Wu, Caixia; Guan, Xiaoyu; Xie, Yudi; Kong, Yujie; Li, Ling; Liu, Zhong.
Afiliación
  • Ren Q; Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, 610052 Chengdu, Sichuan Province, PR China; Key Laboratory of Transfusion Adverse Reactions, Chinese Academy of Medical Sciences, 610052 Chengdu, Sichuan Province, PR China; Zhongshan Central Blood
  • Zhao J; Sichuan Provincial People's Hospital, 610072 Chengdu, Sichuan Province, PR China.
  • He X; Shanxi Bethune Hospital, 030032 Taiyuan, Shanxi Province, PR China.
  • Su L; Guizhou Provincial People's Hospital, 550002 Guiyang, Guizhou Province, PR China.
  • Chai J; Zibo Central Hospital, 255020 Zibo, Shandong Province, PR China.
  • Bai L; The Third People's Hospital of Chengdu, 610014 Chengdu, Sichuan Province, PR China.
  • Ao Z; Chengdu Fifth People's Hospital, Chengdu 611130, Sichuan Province, PR China.
  • Wu C; Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, 610052 Chengdu, Sichuan Province, PR China; Key Laboratory of Transfusion Adverse Reactions, Chinese Academy of Medical Sciences, 610052 Chengdu, Sichuan Province, PR China.
  • Guan X; Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, 610052 Chengdu, Sichuan Province, PR China; Key Laboratory of Transfusion Adverse Reactions, Chinese Academy of Medical Sciences, 610052 Chengdu, Sichuan Province, PR China.
  • Xie Y; Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, 610052 Chengdu, Sichuan Province, PR China; Key Laboratory of Transfusion Adverse Reactions, Chinese Academy of Medical Sciences, 610052 Chengdu, Sichuan Province, PR China.
  • Kong Y; Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, 610052 Chengdu, Sichuan Province, PR China; Key Laboratory of Transfusion Adverse Reactions, Chinese Academy of Medical Sciences, 610052 Chengdu, Sichuan Province, PR China.
  • Li L; Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, 610052 Chengdu, Sichuan Province, PR China; Key Laboratory of Transfusion Adverse Reactions, Chinese Academy of Medical Sciences, 610052 Chengdu, Sichuan Province, PR China. Electronic address: lili
  • Liu Z; Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, 610052 Chengdu, Sichuan Province, PR China; Key Laboratory of Transfusion Adverse Reactions, Chinese Academy of Medical Sciences, 610052 Chengdu, Sichuan Province, PR China. Electronic address: liuz
Transfus Apher Sci ; 62(3): 103700, 2023 Jun.
Article en En | MEDLINE | ID: mdl-36941167
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Transfusión Sanguínea / Enfermedad Crítica Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Transfus Apher Sci Asunto de la revista: HEMATOLOGIA Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Transfusión Sanguínea / Enfermedad Crítica Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Transfus Apher Sci Asunto de la revista: HEMATOLOGIA Año: 2023 Tipo del documento: Article